Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT
Oncotarget · 2025
DOI: 10.18632/oncotarget.28707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2025. Verfasst von Lanlan Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, RI 02903, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, DNA Repair Enzymes, DNA Modification Methylases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, RI 02903, USA.
- Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, RI 02903, USA.
- Joint Program in Cancer Biology, Brown University Health System and Brown University, RI 02903, USA.
- Legorreta Cancer Center at Brown University, RI 02903, USA.
- Department of Medicine, Hematology/Oncology Division, Brown University Health System and Brown University, RI 02903, USA.
- Department of Neurosurgery, Brown University Health and Brown University, RI 02903, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Zhou, L., Zhang, L., Zhang, J., Wu, L. J., Zhang, S., George, A., Hahn, M., Safran, H. P., Chen, C. C., Seyhan, A. A., Wong, E. T., & El-Deiry, W. S. (2025). Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT. Oncotarget. https://doi.org/10.18632/oncotarget.28707
Vancouver
Zhou L, Zhang L, Zhang J, Wu LJ, Zhang S, George A, et al. Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT. Oncotarget. 2025. doi:10.18632/oncotarget.28707
BibTeX
@article{Zhou2025,
author = {Zhou, Lanlan and Zhang, Leiqing and Zhang, Jun and Wu, Laura Jinxuan and Zhang, Shengliang and George, Andrew and Hahn, Marina and Safran, Howard P and Chen, Clark C and Seyhan, Attila A and Wong, Eric T and El-Deiry, Wafik S},
title = {Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT},
journal = {Oncotarget},
year = {2025},
doi = {10.18632/oncotarget.28707}
}
EUVIMED